DarioHealth Corp reports results for the quarter ended in March - Earnings Summary

DarioHealth

11/05/2023 14:32

* DarioHealth Corp  DRIO.OQ  reported quarterly adjusted
earnings
of 45 cents​​ per share for the quarter ended in March. The mean
expectation of five analysts for the quarter was for a loss
of 50 cents per share.
    * Revenue fell 12.3% to $7.07 million from a year ago;
analysts
expected $6.70 million. 
    * DarioHealth Corp's reported EPS for the quarter was 45
cents​.
    * The mean earnings estimate of analysts had risen by
about 15.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * DarioHealth Corp shares had fallen by 10.2% this
quarter and
lost 13.6% so far this year.
    * The company reported quarterly net income of $12.83
million.
    * Wall Street's median 12-month price target for DarioHealth
Corp
is $14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 01:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.50          0.45           Beat
 Dec. 31 2022      -0.65          -0.51          Beat
 Sep. 30 2022      -0.76          -0.64          Beat
 Jun. 30 2022      -0.71          -0.74          Missed